Intensive Weight Loss Intervention and Cancer Risk in Adults with Type 2 Diabetes: Analysis of the Look AHEAD Randomized Clinical Trial

Objective: This study was designed to determine whether intensive lifestyle intervention (ILI) aimed at weight loss lowers cancer incidence and mortality.

Methods: Data from the Look AHEAD trial were examined to investigate whether participants randomized to ILI designed for weight loss would have reduced overall cancer incidence, obesity-related cancer incidence, and cancer mortality, as compared with the diabetes support and education (DSE) comparison group. This analysis included 4,859 participants without a cancer diagnosis at baseline except for nonmelanoma skin cancer.

Results: After a median follow-up of 11 years, 684 participants (332 in ILI and 352 in DSE) were diagnosed with cancer. The incidence rates of obesity-related cancers were 6.1 and 7.3 per 1,000 person-years in ILI and DSE, respectively, with a hazard ratio (HR) of 0.84 (95% CI: 0.68-1.04). There was no significant difference between the two groups in total cancer incidence (HR, 0.93; 95% CI: 0.80-1.08), incidence of nonobesity-related cancers (HR, 1.02; 95% CI: 0.83-1.27), or total cancer mortality (HR, 0.92; 95% CI: 0.68-1.25).

Conclusions: An ILI aimed at weight loss lowered incidence of obesity-related cancers by 16% in adults with overweight or obesity and type 2 diabetes. The study sample size likely lacked power to determine effect sizes of this magnitude and smaller.

Citing Articles

Dietary Restrictions and Cancer Prevention: State of the Art.

Caprara G, Pallavi R, Sanyal S, Pelicci P Nutrients. 2025; 17(3).

PMID: 39940361 PMC: 11820753. DOI: 10.3390/nu17030503.

Tirzepatide and Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis.

Kamrul-Hasan A, Alam M, Dutta D, Sasikanth T, Aalpona F, Nagendra L Endocrinol Metab (Seoul). 2025; 40(1):112-124.

PMID: 39814031 PMC: 11898313. DOI: 10.3803/EnM.2024.2164.

Changes in anthropometry, adiposity, and inflammation in Black and White women engaged in intentional weight loss.

Felix A, Sinnott J, Caan B, Gillespie S, Meade C, Strafford K Obesity (Silver Spring). 2024; 32(12):2398-2409.

PMID: 39496520 PMC: 11589538. DOI: 10.1002/oby.24151.

Mechanisms by Which Pharmacotherapy May Impact Cancer Risk among Individuals with Overweight and Obesity.

Sauter E, Agurs-Collins T Cancers (Basel). 2024; 16(19).

PMID: 39409896 PMC: 11475810. DOI: 10.3390/cancers16193275.

Advances in Diet and Physical Activity in Breast Cancer Prevention and Treatment.

Khalifa A, Guijarro A, Nencioni A Nutrients. 2024; 16(14).

PMID: 39064705 PMC: 11279876. DOI: 10.3390/nu16142262.

References

Luo J, Hendryx M, Manson J, Figueiredo J, LeBlanc E, Barrington W . Intentional Weight Loss and Obesity-Related Cancer Risk. JNCI Cancer Spectr. 2019; 3(4):pkz054. PMC: 6795232. DOI: 10.1093/jncics/pkz054. View

Schauer D, Feigelson H, Koebnick C, Caan B, Weinmann S, Leonard A . Bariatric Surgery and the Risk of Cancer in a Large Multisite Cohort. Ann Surg. 2017; 269(1):95-101. PMC: 6201282. DOI: 10.1097/SLA.0000000000002525. View

Renehan A, Tyson M, Egger M, Heller R, Zwahlen M . Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008; 371(9612):569-78. DOI: 10.1016/S0140-6736(08)60269-X. View

Byers T, Sedjo R . Does intentional weight loss reduce cancer risk?. Diabetes Obes Metab. 2011; 13(12):1063-72. DOI: 10.1111/j.1463-1326.2011.01464.x. View

Duggan C, de Dieu Tapsoba J, Wang C, McTiernan A . Dietary Weight Loss and Exercise Effects on Serum Biomarkers of Angiogenesis in Overweight Postmenopausal Women: A Randomized Controlled Trial. Cancer Res. 2016; 76(14):4226-35. PMC: 5033683. DOI: 10.1158/0008-5472.CAN-16-0399. View

Wing R, Bolin P, Brancati F, Bray G, Clark J, Coday M . Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013; 369(2):145-54. PMC: 3791615. DOI: 10.1056/NEJMoa1212914. View

Chen Y, Liu L, Wang X, Wang J, Yan Z, Cheng J . Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomarkers Prev. 2013; 22(8):1395-408. DOI: 10.1158/1055-9965.EPI-13-0042. View

Adams T, Stroup A, Gress R, Adams K, Calle E, Smith S . Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009; 17(4):796-802. PMC: 2859193. DOI: 10.1038/oby.2008.610. View

. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2014; 2(10):801-9. PMC: 4443484. DOI: 10.1016/S2213-8587(14)70156-1. View

10.

Genkinger J, Spiegelman D, Anderson K, Bernstein L, van den Brandt P, Calle E . A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer. 2010; 129(7):1708-17. PMC: 3073156. DOI: 10.1002/ijc.25794. View

11.

Tsilidis K, Kasimis J, Lopez D, Ntzani E, Ioannidis J . Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015; 350:g7607. DOI: 10.1136/bmj.g7607. View

12.

Ryan D, Espeland M, Foster G, Haffner S, Hubbard V, Johnson K . Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003; 24(5):610-28. DOI: 10.1016/s0197-2456(03)00064-3. View

13.

Eliassen A, Colditz G, Rosner B, Willett W, Hankinson S . Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006; 296(2):193-201. DOI: 10.1001/jama.296.2.193. View

14.

Hursting S, DiGiovanni J, Dannenberg A, Azrad M, LeRoith D, Demark-Wahnefried W . Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res (Phila). 2012; 5(11):1260-72. PMC: 3641761. DOI: 10.1158/1940-6207.CAPR-12-0140. View

15.

Coughlin S, Calle E, Teras L, Petrelli J, Thun M . Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004; 159(12):1160-7. DOI: 10.1093/aje/kwh161. View

16.

Duggan C, de Dieu Tapsoba J, Wang C, Campbell K, Foster-Schubert K, Gross M . Dietary Weight Loss, Exercise, and Oxidative Stress in Postmenopausal Women: A Randomized Controlled Trial. Cancer Prev Res (Phila). 2016; 9(11):835-843. PMC: 5117666. DOI: 10.1158/1940-6207.CAPR-16-0163. View

17.

Sjostrom L, Gummesson A, Sjostrom C, Narbro K, Peltonen M, Wedel H . Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009; 10(7):653-62. DOI: 10.1016/S1470-2045(09)70159-7. View

18.

Moschos S, Mantzoros C . The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology. 2002; 63(4):317-32. DOI: 10.1159/000066230. View

19.

Chen Y, Wang X, Wang J, Yan Z, Luo J . Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer. 2012; 48(14):2137-45. DOI: 10.1016/j.ejca.2012.02.063. View

20.

Wadden T, West D, Delahanty L, Jakicic J, Rejeski J, Williamson D . The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring). 2006; 14(5):737-52. PMC: 2613279. DOI: 10.1038/oby.2006.84. View